EP3707159
Nýstárlegir breyttir frumuviðtakar og ónæmismeðferð þar sem þeir eru notaðir
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.11.2018EP published:
4.1.2023EP application number:
18803349.2
EP translation filed:
31.3.2023Grant published:
15.5.2023EPO information:
European Patent Register
Max expiry date:
4.11.2038Expiry date:
4.11.2026Next due date:
30.11.2026
Title in English:
NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAMELanguage of the patent:
English
Timeline
Today
5.11.2018EP application
4.1.2023EP Publication
31.3.2023Translation submitted
15.5.2023Registration published
4.11.2026Expires
Owner
Name:
Immatics Biotechnologies GmbHAddress:
Paul-Ehrlich-Strasse 15, 72076 Tübingen, DE
Inventor
Name:
UNVERDORBEN, FelixAddress:
70199 Stuttgart, DE
Name:
BUNK, SebastianAddress:
72074 Tübingen, DE
Name:
HOFMANN, MartinAddress:
72076 Tübingen, DE
Name:
HUTT, MeikeAddress:
70565 Stuttgart, DE
Name:
MAURER, DominikAddress:
72116 Moessingen, DE
Name:
ALTEN, LeonieAddress:
72076 Tübingen, DE
Name:
WAGNER, ClaudiaAddress:
72074 Tübingen, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
102017125888Date:
6.11.2017Country:
DE
Number:
201762582202 PDate:
6.11.2017Country:
US
Classification
Categories:
A61K 39/00, A61P 35/00, C07K 16/18, C07K 14/725, C07K 14/78, C07K 16/28, C07K 16/30, C12N 5/0783, C12N 15/62
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 23.11.2023
Expires: 4.11.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 15.11.2024
Expires: 4.11.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.11.2025
Expires: 4.11.2026
Payer: Árnason Faktor ehf.